• 1
    Gluckmann PD. Intrauterine growth retardation: future research directions. Acta Paediatr Suppl 1993; 388: 9699.
  • 2
    Friedman SA. Preeclampsia: a review of the role of prostaglandins. ObstetGynecol 1988; 71: 122137.
  • 3
    McParland P, Pearce JM, Chamberlain GVP. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; 335: 15521555.
  • 4
    Uzan S, Beaufils M, Breart G, Bazin B, Capitant C, Paris J. Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 1991; 337: 14271431.
  • 5
    Hauth JC, Goldenberg RL, Parker CR Jr et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993; 168: 10831093.
  • 6
    Khong TY, de Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age babies. Br J Obstet Gynaecol 1986; 93: 10491059.
  • 7
    Imperiale TF, Petrulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 260265.
  • 8
    Sanchez-Ramos L, Wears R, Del Valle GO, Gaudier FL, Adair D. Low-dose aspirin for the prevention of pregnancy-induced hypertension: a meta-analysis [abstract]. Am J Obstet Gynecol 1994: 408.
  • 9
    CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619629.
  • 10
    Collins R. Antiplatelet agents for IUGR and pre-eclampsia [revised 4 May 1994]. In: KeirseMJNC, RenfrewMJ, NeilsonJP, CrowtherC, editors. Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2. Oxford : Update Software, 1995.
  • 11
    Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987; 6: 341348.
  • 12
    Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Statistics in Medicine 1991; 10: 16651677.
  • 13
    Light RJ, Pillemer DB. Summing Up: the Science of Review Research. Cambridge , Massachusetts : Harvard University Press, 1984.
  • 14
    Trudinger BJ, Cook CM, Thompson RS, Giles WB, Connelly A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988; 159: 681685.
  • 15
    Schiff E, Barkai G, Ben-Baruch G, Mashiach S. Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension. Obstet Gynecol 1990; 76: 742744.
  • 16
    Wang ZH, Li WJ. Prevention of fetal growth retardation by low dose aspirin. Chinese Journal of Obstetrics and Gynecology 1993; 28: 492495.
  • 17
    Rogov VA, Tareeva IE, Sidorova IS, Androsova SO, Katamadze KT, Nikiforova OV. Acetylsalicylic acid and kurantil in the prevention of pregnancy complications in glomerulonephritis and hypertension. Terapevticheskii Arkhiv 1993; 65: 6568.
  • 18
    Italian study of aspirin in pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy- induced hypertension. Lancet 1993; 341: 396400.
  • 19
    Beaufils M, Uzan S, Donsimoni R, Colau J. C. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840842.
  • 20
    Benigni A, Gregorini G, Frusca T et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357362.
  • 21
    Schiff E, Peleg E, Goldenberg M et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351356.
  • 22
    Schrocksnadel H, Sitte B, Alge A et al. Low-dose aspirin in primi-gravidae with positive roll-over test. Gynecol Obstet Invest 1992; 34: 146150.
  • 23
    Sibai BM, Caritis SN, Thorn E et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 1993; 329: 12131218.
  • 24
    Caspi E, Raziel A, Sherman D, Arieli S, Bukovski I, Weinraub Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. Am J Reprod Immunol 1994; 31: 1924.
  • 25
    Leroy B, Lefort F. A propos du poids et de la taille des nouveaux nes a la naissance. Rev Fr Gynecol 1971; 66: 391396.
  • 26
    Kloosterman GJ. On intrauterine growth. Int J Gynecol Obstet 1970; 8: 895912.
  • 27
    Lubchenco LO, Searls DT, Brazie JV. Neonatal mortality rate: relationship to birthweight and gestational age. J Pediatr 1972; 81: 814822.
  • 28
    Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126: 555564.
  • 29
    Prazzini F, Cortinovis I, Bortolus R, Fedele L. Standard of weight at birth in Italy. Annali di Ostetricia, Ginecologia, Medicina Perinatale 1991; 112: 203246.
  • 30
    Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birthweight and head circumference centiles for gestational age 24–42 weeks. Early Hum Dev 1987; 15: 4552.
  • 31
    Wallenburg HCS, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 13.
  • 32
    Viinikka L, Hartikainen-Sorri AL, Lumme R, Hiilesmaa V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. Br J Obstet Gynaecol 1993; 100: 809815.
  • 33
    Levin DL, Mills LJ, Weinberg AG. Hemodynamic, pulmonary, vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus: a possible mechanism for per- sistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant. Circulation 1979; 60: 360364.
  • 34
    Rumack CM, Guggenheim MA, Rumack BH, Peterson RG, Johnson ML, Braithwaite WR. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol 1981; 58 Suppl: 528568.
  • 35
    Shapiro S, Monson RR, Kaufman DW, Siskind V, Heinonen OP, Slone D. Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy. Lancet 1976; 2: 13751376.
  • 36
    Streissguth AP, Treder RP, Barr HM. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology 1987; 35: 211219.
  • 37
    Klebanoff MA, Berendes HW. Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology 1988; 37: 249255.
  • 38
    Werler MM, Mitchell AA, Shapiro S. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989; 321: 16391642.
  • 39
    Saling E. Versuch einer neuen kompensatorischen Versorgung des hypotrophen Fetus. Geburtsh Frauenheilk 1987; 47: 9092.
  • 40
    Attalah AN, Collins R, Farrell B et al. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol 1996; 103: 3947.